BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20413535)

  • 1. Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia.
    Malo de Molina R; Mortensen EM; Restrepo MI; Copeland LA; Pugh MJ; Anzueto A
    Eur Respir J; 2010 Oct; 36(4):751-7. PubMed ID: 20413535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.
    Chen D; Restrepo MI; Fine MJ; Pugh MJ; Anzueto A; Metersky ML; Nakashima B; Good C; Mortensen EM
    Am J Respir Crit Care Med; 2011 Aug; 184(3):312-6. PubMed ID: 21512168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
    Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
    Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ; Au DH; Fitzgibbon ML; Lee TA
    Respir Med; 2010 Feb; 104(2):246-52. PubMed ID: 19879745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalization for chronic obstructive pulmonary disease and pneumonia: association with the dose of inhaled corticosteroids. A nation-wide cohort study of 52 100 outpatients.
    Rønn C; Sivapalan P; Eklöf J; Kamstrup P; Biering-Sørensen T; Bonnesen B; Harboe ZB; Browatzki A; Kjærgaard JL; Meyer CN; Jensen TT; Johansson SL; Bendstrup E; Ulrik CS; Stæhr Jensen JU
    Clin Microbiol Infect; 2023 Apr; 29(4):523-529. PubMed ID: 36503112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
    Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
    BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan.
    Hirano R; Fujita M; Matsumoto T; On R; Watanabe K
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3503-3509. PubMed ID: 30498340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and Risk of Pneumonia: A Nested Case-Control Population-based Study in Lazio (Italy)-The OUTPUL Study.
    Cascini S; Kirchmayer U; Belleudi V; Bauleo L; Pistelli R; Di Martino M; Formoso G; Davoli M; Agabiti N
    COPD; 2017 Jun; 14(3):311-317. PubMed ID: 28406337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia.
    Singanayagam A; Chalmers JD; Akram AR; Hill AT
    Eur Respir J; 2011 Jul; 38(1):36-41. PubMed ID: 21429980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study.
    Kendzerska T; Aaron SD; To T; Licskai C; Stanbrook M; Vozoris NT; Hogan ME; Tan WC; Bourbeau J; Gershon AS
    Ann Am Thorac Soc; 2019 Oct; 16(10):1252-1262. PubMed ID: 31298938
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.
    Cheng SL; Su KC; Wang HC; Perng DW; Yang PC
    Drug Des Devel Ther; 2014; 8():601-7. PubMed ID: 24920884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
    Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
    COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD.
    Oshagbemi OA; Franssen FME; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Boer A; de Vries F
    Pulm Pharmacol Ther; 2020 Feb; 60():101870. PubMed ID: 31785343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.